3.710SEK+3.34%Mkt Cap: 97.26M SEKP/E: —Last update: 2026-06-01
Scandinavian ChemoTech AB (publ), a medical technology company, engages in the radiation physics, surgical oncology, and clinical development in Sweden and internationally. It operates in two divisions, Human Care and An…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap97.26M SEK
Enterprise Value89.92M SEK
Revenue (TTM)12.61M SEK
Gross Profit10.30M SEK
Net Income (TTM)-8.06M SEK
Revenue/Share0.5140 SEK
Last Price3.710 SEK
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees1
CountrySE
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-17.65
EV/Revenue7.13
P/S7.46
P/B56.09
EPS (TTM)-0.24
EPS (Forward)—
52W Range
1.45536% of range7.760
52W High7.760 SEK
52W Low1.455 SEK
Profitability
Gross Margin83.81%
Oper. Margin-49.29%
EBITDA Margin-40.39%
Profit Margin-65.58%
ROE-252.86%
ROA-61.03%
Growth
Revenue Growth13.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF-3.75M SEK
CapEx (TTM)437.00K SEK
FCF Margin-12.69%
FCF Yield-1.65%
Net Debt-1.46M SEK
Net Debt/EBITDA0.29
Balance Sheet
Debt/Equity0.00
Current Ratio0.79
Quick Ratio0.46
Book Value/Sh0.0640 SEK
Cash/Share0.0570 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 SEK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)6.300 SEK
Target Range6.300 SEK – 6.300 SEK
# Analysts1
Ownership
Shares Out.23.80M
Float13.07M
Insiders42.26%
Institutions3.37%
Technical
SMA 503.773 (-1.7%)
SMA 2004.242 (-12.5%)
Beta1.12
S&P 52W Chg27.70%
Avg Vol (30d)12.00K
Avg Vol (10d)11.88K
Technical Indicators
RSI (14)47.3
MACD-0.0820
MACD Signal-0.0710
MACD Hist.-0.0110
BB Upper4.043 SEK
BB Middle3.669 SEK
BB Lower3.295 SEK
BB Width20.38%
ATR (14)0.2806 SEK
Vol Ratio (20d)0.07x